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Abstract
UV damage activates cellular stress signaling pathways, causes DNA helix distortions and inhibits transcription by RNA
polymerases I and II. In particular, the nucleolus, which is the site of RNA polymerase I transcription and ribosome
biogenesis, disintegrates following UV damage. The disintegration is characterized by reorganization of the subnucleolar
structures and change of localization of many nucleolar proteins. Here we have queried the basis of localization change of
nucleophosmin (NPM), a nucleolar granular component protein, which is increasingly detected in the nucleoplasm
following UV radiation. Using photobleaching experiments of NPM-fluorescent fusion protein in live human cells we show
that NPM mobility increases after UV damage. However, we show that the increase in NPM nucleoplasmic abundance after
UV is independent of UV-activated cellular stress and DNA damage signaling pathways. Unexpectedly, we find that
proteasome activity affects NPM redistribution. NPM nucleolar expression was maintained when the UV-treated cells were
exposed to proteasome inhibitors or when the expression of proteasome subunits was inhibited using RNAi. However, there
was no evidence of increased NPM turnover in the UV damaged cells, or that ubiquitin or ubiquitin recycling affected NPM
localization. These findings suggest that proteasome activity couples to nucleolar protein localizations in UV damage stress.
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Introduction
The nucleolus is a membraneless nuclear organelle that governs
ribosome biogenesis. It is physically formed around hundreds of
ribosomal gene repeats. In the nucleolus, RNA polymerase I (Pol I)
transcribes ribosomal (r) DNA into rRNA [1,2]. The nucleolus is
composed of substructures, which correspond to the vectorial
movement and processing of the maturing rRNA transcripts. In
higher eukaryotes, transcription of the 47S rRNA precursor is
initiated at the border of fibrillar centers (FC) and dense fibrillar
centers (DFC). The 47S transcript is then cleaved to 28S, 18S and
5.8S rRNAs [3,4]. The transcripts are further modified in the
DFC, and assembled in the granular component (GC) together
with ribosomal proteins and 5S RNA into ribosomal subunits,
which are then transported to cytoplasm where fully active
ribosomes are formed [3]. Since ribosomes are prerequisite for all
cellular protein production their amount is rate limiting in cell
proliferation. 50% or more of total cellular transcription of rapidly
proliferating cells results from rRNA transcription. Therefore,
ribosome biogenesis and the synthesis of rRNA is strictly
controlled [5,6].
The nucleolus harbors a substantial number of distinct proteins
requisite for the rRNA biogenesis. More than 4500 proteins have
been identified in the nucleolus [7], several of which are highly
dynamic within their subcellular localization [8,9]. Due to the
divergent functions of the nucleolar proteome, the nucleolus has
been proposed to participate in additional cellular processes.
Nucleolar proteins have been reported to regulate tumor
suppressor protein and oncogene activities, cell cycle, signal
recognition particle assembly, to modify small RNAs, control
aging and telomerase function, to regulate mitosis, cell growth and
death, and to function as sensors for cellular stress [10–14]. In
addition, many ribosomal proteins have extra-ribosomal functions
that are disconnected of ribosome biogenesis [15,16].
We have previously shown that a multifunctional and an
abundant nucleolar protein nucleophosmin (NPM, B23) reloca-
lizes from the nucleolus to the nucleoplasm following UV damage
[17]. UV radiation is a major environmental carcinogen, which
causes formation of DNA helix distorting adducts [18]. These
form physical barriers that halt the transcription by RNA
polymerases and evoke complex cellular stress responses [19].
To date, it is not known what controls the change in NPM
localization after UV radiation. Consequent to UV-mediated
NPM relocalization to the nucleoplasm it binds MDM2 and
protects p53 from MDM2-mediated proteasomal degradation
[17]. In addition, similar functions have been published for several
ribosomal proteins in a process termed as nucleolar or ribosomal
stress, where nucleolar disruption is followed by p53 stabilization
[20,21]. We have recently detailed, using quantitative proteomics
and cellular imaging, the responses of hundreds of nucleolar
proteins to DNA damage caused by UV and ionizing radiation
[22]. We showed that the nucleolar expression of a marked
number of proteins changes after UV, while the changes following
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ionizing radiation are less dynamic and involve only a subset of
proteins. What directs these dynamic changes is unknown.
Protein degradation is an essential cellular process, in which
excess and misfolded proteins are degraded. The major degrada-
tion pathway in eukaryotic cells is the ubiquitin-proteasome
system, where ubiquitin is repeatedly added to targeted proteins by
specific enzymes (E1, E2 and E3) in a strictly controlled manner
[23]. Polyubiquitin chains formed by K48 and K11-linkages are
recognized by the proteasome leading to degradation of poly-
ubiquitinated proteins. Inhibition of proteasome function causes
accumulation of polyubiquitinated proteins, which may lead to
severe cellular stress and cell death. This feature is utilized in
cancer therapy through the use of chemical proteasome inhibitors
[24].
Recent evidence indicates a functional interplay between the
nucleolus and proteasome function. Proteasome inhibitor treat-
ment alters nucleolar morphology, inhibits nucleolar rRNA
processing [25–27], and causes accumulation of ribosomal
proteins in the nucleolus [28]. Ubiquitin has been detected in
the nucleolus [25], also in the conjugated form [27], and is
relevant in the clearance of nonfunctional ribosomes and rRNAs
[29]. Several ribosomal proteins are conjugated by ubiquitin, or
expressed as ubiquitin-fusion proteins [21,30,31]. 20S proteasome
core has been detected in the nucleolus in certain conditions
[27,32,33] although there are reports that contrast this result [34].
It has been suggested that the nucleolus directly controls the
proteasomal degradation of certain proteins, like c-Myc and p53
[33,35]. We have recently identified a nucleolus-associated RNA-
protein aggregate, which forms following proteasome inhibition,
and is alleviated by ectopic expression of ubiquitin suggesting that
inhibition of ubiquitin recycling contributes to the nucleolar
accumulation [27]. Finally, a nucleolar deubiquitinase USP36
regulates nucleolar activity by affecting nucleolar morphology and
inhibiting rRNA transcription and processing [36]. The majority
of functional links between the nucleolus and proteasome
implicates association of the ubiquitin pathway in nucleolar
control.
We investigate here the UV damage-activated processes that
relate to the changes in localization of nucleolar proteins. In this
context, we considered pathways relevant in UV- mediated
intracellular stress signaling, DNA damage signaling and the
proteasome activity. We show here that proteotoxic stress inhibits
the UV radiation –activated relocation of NPM and other GC-
proteins. Interestingly, it is independent of ubiquitin availability as
demonstrated by genetic manipulation of several ubiquitin
conjugating factors. Conversely, we show that genetic silencing
of 20S proteasome core by RNAi leads to inhibition of UV
damage –mediated NPM relocation, suggesting that the protea-
some is essential for NPM localization change after UV stress.
Results
NPM nucleolar mobility is increased following UV
damage
NPM is highly mobile, and the mobility is further increased
after inhibition of RNA Pol I by low doses of Actinomycin D [37].
We have shown a change in NPM localization from the nucleolus
to the nucleoplasm following UV damage [17], and wanted hence
to ascertain whether this is associated with a change in NPM
mobility. We transiently transfected U2OS cells with NPM tagged
with enhanced cyan green fluorescent protein (ECGFP) and used
fluorescence recovery after photobleaching (FRAP) to record its
intensity in nucleoli of untreated and UV-treated cells at different
times after damage (Fig. 1A). The mobility of NPM-ECGFP was
high already in untreated control cells as indicated by mobile
fraction (Mf) calculated from the intensity data (89%, Fig. 1B).
Following UV damage, the mobility of NPM-ECGFP further
increased to 92% and 99% at 1 and 3 hours after damage,
respectively (Fig. 1B). We determined also protein recovery half
times (T1/2), i.e. how fast NPM-ECGFP fluorescence recovers to
half of the original level. UV damage affected recovery half times
of NPM-ECGFP, changing from 4.3 seconds in control to 7.6 and
3.0 seconds at 1 and 3 hours after UV damage, respectively. Over
time, NPM-ECGFP was increasingly detected in the nucleoplasm,
and a similar FRAP-analysis indicated that the nucleoplasmic
NPM-ECGFP was fully mobile (Mf = 100%, Fig. S1). These
results indicate that after UV damage NPM mobility increases
concomitant with a more prominent nucleoplasmic localization.
The longer T1/2 observed 1 hour after UV damage may relate to
transient NPM associations early after the UV damage and will
need to be investigated in further in-depth imaging analyses.
Proteotoxic stress inhibits UV damage–mediated NPM
relocalization
It is not known what causes NPM redistribution after UV
damage. In order to query putative regulators of the process, we
inhibited factors that function in signaling pathways activated by
UV radiation and DNA damage. For this purpose we used specific
inhibitors for MEK, p38, JNK, ATM, ATR/ATM, and DNA-PK
pathways and pretreated cells with respective inhibitors for 1 hour
before irradiation with UV. Since we have previously shown a link
between proteasome activity and nucleolar function [27], we
tested also a proteasome inhibitor in this setting. We fixed the cells
after 3 hours and performed co-immunostaining for NPM and
UBF. By using UBF as a nucleolar marker, we imaged and
quantified the ratio of the nucleolar and nucleoplasmic NPM
intensity (Fig. 2A). NPM localization ratio altered significantly in
the control and UV-treated cells. However, none of the inhibitors
that block UV-activated signaling pathways or DNA damage
response pathways had any effect on the UV-mediated NPM
translocation (Fig. 2A and Fig. S2). In contrast, proteasome
inhibitor MG132 effectively inhibited NPM relocalization by UV
damage (Fig. 2A).
We further confirmed the effect by using another specific
proteasome inhibitor, lactacystin. WS1 cells were pre-treated with
either MG132 or lactacystin for 1 hour followed by UV radiation.
We fixed the cells after 6 hours, and performed immunostaining
for NPM. Similarly to MG132, pretreatment with lactacystin
inhibited NPM nucleoplasmic localization (Fig. 2B). In order to
confirm that the effect was not selective for the NPM antibody
used in the assay, we used U2OS cells stably expressing NPM-
ECGFP and exposed them to UV in the presence or absence of
MG132. MG132 inhibited NPM-ECGFP nucleoplasmic localiza-
tion following UV similarly to the endogenous NPM (Fig. S3A). In
order to determine whether the effect was due to change in overall
NPM protein level, we detected NPM expression by western
blotting in WS1, U2OS and HeLa cells treated with MG132 and
UV. There was no change in the total NPM protein level by UV
or MG132 in any of the cell lines (Fig. 2C, Fig. S3B). To further
query whether UV damage changes NPM turnover, we assessed
NPM stability in UV-treated cells by inhibiting de novo protein
synthesis using cycloheximide. As shown in Figures S4A and B,
there was no change in NPM half-life following UV treatment, nor
did cycloheximide affect NPM localization (Fig. S4C). Similarly,
we addressed whether inhibition of RNA polymerase II transcrip-
tion affects UV-dependent NPM localization using a-amanitin,
and could not observe any change (Fig. S4D). In conclusion,
proteasome inhibitors MG132 and lactacystin inhibited the UV
Proteasome Influences NPM Relocalization
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damage–mediated change in NPM localization without an
apparent change in NPM expression.
Proteasome inhibition decreases NPM mobility in UV-
treated cells
As shown in Figure 1, UV treatment increased the mobility of
NPM-ECGFP. As proteasome inhibition has been shown to affect
the mobility of certain nucleolar proteins, including NPM [25,27],
we wanted to test whether NPM mobility was affected by MG132
treatment in combination with UV damage. We performed
FRAP–experiments on U2OS cells stably expressing NPM-
ECGFP after treating the cells with UV, MG132 or their
combination (Fig. 3). Whereas UV damage increased NPM-
ECGFP mobility (Mf 94% as compared to control 88%), MG132
decreased the mobility (Mf 69%). Interestingly, in cells treated with
both MG132 and UV, NPM-ECGFP mobility was further
decreased (Mf 60%). Similar recovery half times were observed
for control and UV-treated cells as in Fig. 1. The T1/2 in MG132-
treated cells was slightly delayed as compared to control. However,
in cells exposed to both MG132 and UV, the T1/2 was
indistinguishable from control indicating that despite decreased
mobility, the recovery half time was maintained (Fig. 3). This
indicates that proteasome inhibition affects NPM mobility even in
the context of UV damage.
Effects of proteasome inhibition on nucleolar protein
localization are not limited to NPM
Next we wanted to test whether proteasome inhibition affects
the UV-mediated localization change of also other nucleolar
proteins. We assayed for localization of nucleolar proteins with
specific localizations in nucleolar substructures, FC, DFC and GC.
We treated WS1 cells with MG132 and UV and immunostained
the cells for GC-proteins nucleolin (NCL) and nucleostemin
(GNL3). UV damage decreased nucleolar staining intensity of
both NCL and GNL3, whereas pretreatment of the cells with
MG132 inhibited both effects (Fig. 4A). DFC protein fibrillarin
(FBL) and FC protein UBF did not display nucleoplasmic
localization following UV (Fig. 4B). Rather, both form nucleolar
necklaces around the nucleolus following UV [22] and transcrip-
tional inhibition [38]. MG132-treatment, which alters the
nucleolar substructures [27], did not inhibit DFC and FC protein
reorganization following UV (Fig. 4B). As determined by western
blotting there was no change in the expression of NCL, GNL3,
FBL or UBF (Fig. 4C).
rRNA biogenesis is inhibited at different stages by UV
and proteasome inhibition
UV radiation represses rRNA transcription [22,39,40], whereas
MG132 inhibits late rRNA processing, but not rRNA synthesis
[25–27]. We hence wanted to assess whether MG132 treatment
impacts UV damage-mediated inhibition of rRNA transcription.
First, we treated cells with UV in the presence or absence of
MG132 alone and labeled the cells with ethynyl uridine (EU) for
Figure 1. NPM nucleolar mobility is increased following UV radiation. A U2OS cells were transiently transfected with NPM-ECGFP and
treated with UVC (35 J/m2) or left untreated (control). FRAP analysis was performed on a single nucleolus as indicated by ROI (red circle). Following
photobleaching images were captured every 1 s for 100 s. Representative images are shown. Scale bar 10 mm. B Averages of normalized intensities,
mobile fraction (Mf) and recovery half times (T1/2) from at least two independent experiments for each treatment are shown. Error bars, SD. N $ 8
cells for each treatment.
doi:10.1371/journal.pone.0059096.g001
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the last hour of incubation. Incorporation of EU was detected with
azide-containing dye. UV radiation reduced the EU incorporation
significantly, whereas MG132-treatment alone had only a minor,
non-significant effect (Fig. 5A and B). MG132 had no effect on the
UV-mediated repression of EU incorporation (Fig. 5A and B). To
assess the synthesis and processing of the 47S rRNA to the mature
18S and 28S rRNAs, we used metabolic labeling of nascent rRNA
with 3H-uridine. Cells were treated with MG132 and UV followed
by incubation with 3H-uridine. RNA was extracted, separated in
agarose gel and autoradiograms were obtained. UV radiation fully
inhibited the synthesis of the pre-rRNA 47S transcript and
decreased the levels of the 32S processed form and 28S mature
rRNA (Fig. 5C). However, 18S rRNA was still detectable. MG132-
treatment alone did not affect the 47S or 32S transcript synthesis
indicating that the rRNA transcription or early processing per se
was not affected (Fig. 5C). Expression of the 28S mature form was
reduced suggesting inhibition of late processing. The quantified
intensity of all rRNAs was lower in MG132-treated cells than in
control (Fig. 5D). These results are in concordance with the earlier
published results of MG132 as a processing inhibitor [26]. Finally,
MG132-treatment did not rescue the UV-damage caused repres-
sion of rRNA synthesis as evident by the loss of the 47S transcript
(Fig. 5C). These data show that proteasome inhibition and UV
damage cause defects in rRNA biogenesis at different steps, and
that proteasome inhibition does not compensate for the UV-
mediated inhibition of rRNA synthesis.
Ubiquitin recycling does not affect NPM response to UV
and proteotoxic stress
Inhibition of the proteasome has two main effects on the cells.
Due to inhibition of the catalytic activity of the proteasome, it
leads to accumulation of polyubiquitinated proteins. Secondly, it
leads to depletion of free ubiquitin normally released during
processing of the polyubiquitinated proteins through the protea-
some. Consequently, the lack of ubiquitin would also affect other
processes, such as monoubiquitination, where the monoubiquitin
tags serve as signals for protein localization or other specified
Figure 2. UV-activated NPM relocalization is prevented by
treatment with proteasome inhibitor. A U2OS cells were treated
with inhibitors targeting UV-activated cellular signaling (U0126 10 mM
for MEK, SB203580 20 mM for p38 and SP600125 100 mM for JNK), DNA
damage signaling (KU55933 10 mM for ATM, wortmannin 100 mM for
ATM/ATR and NU7441 10 mM for DNA-PK) and proteasome (MG132
10 mM) or left untreated. One hour later the cells were exposed to UV
radiation (35 J/m2) or left untreated. Cells were fixed after 3 hours and
stained for NPM and UBF. Cells were imaged and intensities were
quantified with Fiji-software using UBF as a nucleolar marker. The ratio
of nucleolar and nucleoplasmic intensities was calculated from three
independent experiments with two fields imaged per experiment. P-
values were calculated using Student’s T test, *P,0.05; **P,0.01;
***P,0.001. Error bars, SD. N $ 140 cells/analysis. B WS1 cells were
treated with proteasome inhibitors MG132 (10 mM) or lactacystin (LC,
10 mM) for 1 hour prior to UV radiation (35 J/m2) or left untreated. The
cells were fixed 6 hours later and stained for NPM. Scale bar 20 mm. C
WS1 cells were treated with MG132 or left untreated. After 1 hour the
cells were treated with UV radiation (35 J/m2) or left untreated. Cells
were lysed 3 hours later into RIPA buffer. Equal amounts of total protein
were separated by SDS-PAGE and immunoblotted for NPM. Tubulin was
used as a loading control.
doi:10.1371/journal.pone.0059096.g002
Figure 3. Nucleolar mobility of NPM is altered after protea-
some inhibition and UV damage. U2OS cells stably expressing
NPM-ECGFP were treated either with MG132 (10 mM) for 4 hours, UV
(35 J/m2), pretreated with MG132 for 1 hour followed by UV treatment
(35 J/m2) and incubation for 3 hours, or left untreated (control).
Averages of normalized intensities, mobile fractions (Mf) and recovery
half-times (T1/2) from at least three independent experiments for each
treatment are shown. Error bars, SD. N= 5–8 cells for each treatment.
doi:10.1371/journal.pone.0059096.g003
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functions. We have recently shown that ubiquitin availability is
important in nucleolar function upon proteasome inhibition [27].
We therefore considered that ubiquitin tags might be relevant in
the UV-mediated translocation of nucleolar proteins and become
rate-limiting when cells were exposed to MG132 treatment. To
assess this we overexpressed HA-tagged ubiquitin in U2OS cells
and treated the cells with UV, MG132 or their combination. We
fixed the cells and stained them for NPM and HA-ubiquitin. We
imaged and quantified NPM nucleolar area in HA-tagged
ubiquitin negative and positive cells separately. Overexpression
of ubiquitin did not markedly affect the nucleolar retention of
NPM in UV-treated cells by MG132 (Fig. 6A).
We then considered the possibility that ubiquitin tags
themselves, present on the nucleolar proteins, would cause the
retention of NPM in the nucleolus. Previously we showed that
overexpression of HAUSP (herpesvirus-associated ubiquitin-spe-
cific protease, USP7) deubiquitinase counteracts nucleolar aggre-
gate formation [27]. Hence we tested whether HAUSP affects
NPM localization. We overexpressed Flag-tagged HAUSP in
U2OS cells and determined NPM localization in UV and
MG132-treated cells. Cells were stained for NPM and Flag-
HAUSP. Quantification of NPM nucleolar area both in HAUSP
negative and positive cells indicated that overexpression of Flag-
HAUSP had no effect on NPM localization by any of the
treatments (Fig. 6B). We also tested whether a nucleolar
deubiquitinase USP36, which deubiquitinates NPM [41], affects
the MG132-caused NPM nucleolar retention in the UV-treated
cells. We stably expressed Flag-tagged USP36 in U2OS cells and
treated the cells with UV radiation, MG132 or their combination.
We fixed the cells and stained them for NPM and Flag-USP36.
Quantified analysis of NPM indicated that expression of Flag-
USP36 had no effect on NPM localization by any of the
treatments (Fig. 6C).
MDM2, an E3 ligase for p53 has been suggested to be a
potential regulator for GTP-depletion –induced nucleostemin
redistribution [42], although this hypothesis has recently been
challenged [43]. We therefore tested whether Nutlin-3, an
inhibitor of MDM2 activity affects NPM localization. We treated
U2OS cells with Nutlin-3, UV or their combination. Nutlin-3 had
no effect on NPM localization, either alone or in UV–treated cells
(Fig. S5).
We then tested whether ubiquitin conjugation affects NPM
localization, and used a ubiquitin E1-ligase inhibitor [44] for this
purpose. We pre-treated cells with UbE1-inhibitor for 24 hours
followed by treatment of the cells with or without UV. We
confirmed the activity of UbE1-inhibitor separately as detected by
increased expression of p53 (Fig. S6). We fixed the cells after
3 hours, stained them for NPM, and imaged and quantified NPM
nucleolar area. Treatment with UbE1-inhibitor had no effect on
the UV-mediated NPM localization, suggesting that ubiquitin
conjugation was not an essential mediator of NPM localization
(Fig. 6D). In conclusion, manipulation of ubiquitin recycling by
several different ways did not affect NPM translocation by UV
damage.
Inhibition of proteasome expression prevents NPM
localization change
Finally, despite that there was no apparent indication that UV
damage affects NPM proteasomal turnover we proceeded with
genetic inhibition of the proteasome, specifically by silencing 20S
core subunits responsible for its catalytic activity. We silenced the
20S a and b subunits in U2OS cells using siRNA, and used a
random non-targeting siRNA as control. Silencing was confirmed
Figure 4. Nucleolar protein UV responses and proteasome inhibition are divergent and depend on the nucleolar subcompartment.
WS1 cells were pretreated with MG132 followed by UV radiation (35 J/m2) as shown. Cells were fixed after 3 hours and stained for NCL and GNL3 (A),
or FBL and UBF (B). Confocal images are shown for FBL and UBF (B). Scale bar 20 mm. C Western blotting analysis for the respective proteins. Equal
amounts of total protein were separated by SDS-PAGE and immunoblotted for NCL, GNL3, FBL and UBF. Tubulin was used as a loading control.
doi:10.1371/journal.pone.0059096.g004
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by immunological detection of the 20S subunits (Fig. 7A and B and
Fig. S7). We treated the cells with UV for 3 hours, fixed and
stained the cells for NPM and 20S and quantified NPM nucleolar
area. The UV-mediated NPM localization change was clearly
inhibited in cells that underwent effective silencing of either 20S a
or b subunit (Fig. 7A, B and C). This suggests that the proteasome is
needed for the observed change in NPM location by UV radiation.
Discussion
Here we have investigated the regulation of NPM relocation
after UV radiation. We found that proteasome inhibition
effectively blocks the UV–mediated NPM translocation, but that
it was independent of UV damage-activated cellular stress and
signaling pathways. In addition to NPM, also other nucleolar GC-
proteins were similarly affected and an increase in their
nucleoplasmic expression was substantially inhibited by MG132.
We found that ubiquitin or ubiquitin recycling were not requisite
for these activities, but that the activity of the proteasome was
essential for the observed changes in NPM protein localization by
UV. However, UV damage did not affect the apparent NPM
protein level or half-life, suggesting that NPM by itself is not
proteasomally targeted. These findings suggest that the decrease of
NPM nucleolar association reflects nucleolar disintegration and
nucleoplasmic redistribution of nucleolar proteins and their
complexes. In this context, the nucleoplasmic redistribution
appears to depend on proteasome-dependent turnover, raising
the possibility that NPM is associated with proteins or protein
complexes that are subject to proteasome-dependent regulation.
We have shown previously that UV-damage causes widespread
dynamic changes in the expression and localization of nucleolar
proteins [22]. These changes were documented by quantitative
mass spectrometry, cellular imaging and biochemical means, and
showed that while a large number of nucleolar proteins were
affected by UV, ionizing radiation had a much more limited
impact [22]. These findings made us question what underlies the
UV-activated drastic changes in nucleolar protein localization.
Further, although there are many detailed studies on downstream
effects of nucleolar disruption, it is not clear what triggers the
localization changes [45]. Since the nucleolus is predominantly
formed around active transcription sites [46], disruption of the
nucleolus and subsequent protein relocation may represent loss of
transcription. However, this view has recently been challenged by
demonstration that not all nucleolar proteins are similarly affected,
and that even under transcription stress certain proteins accumu-
late into the nucleolus [22,28]. Furthermore, UV damage causes a
complex activation of cellular signaling networks, including
activation of intracellular stress signaling cascades and DNA
Figure 5. rRNA transcription and processing are inhibited after proteasome inhibition and UV radiation. A U2OS cells were pretreated
with MG132 followed by UV radiation (35 J/m2) as shown. Cells were incubated for 3 hours and labeled with 1 mM EU for the last hour. Cells were
fixed and EU labeling was detected by azide-containing dye. Scale bar 20 mm. B EU nuclear signal was quantified from two independent experiments.
P-values were calculated using Student’s T test, *P,0.05; **P,0.01; ***P,0.001. Error bars, SD. N= 51–70 cells for each analysis. C A375 cells were
pretreated with MG132 followed by UV radiation (35 J/m2) as shown and incubated for 3 hours. Cells were labeled with 3H-uridine for the last 1 hour,
and RNA was extracted. Equal amounts of RNA were separated by 1% agarose-formaldehyde gel and transferred onto nylon filter. Representative
autoradiogram is shown and rRNA forms are indicated on the left. D 3H-uridine labeling was quantified by Fiji/ImageJ-software from two
independent experiments. P-values were calculated by Student’s T test, *P,0.05; **P,0.01; ***P,0.001. Error bars, SD.
doi:10.1371/journal.pone.0059096.g005
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Figure 6. Ubiquitin recycling does not contribute to inhibition of NPM relocalization following UV radiation. U2OS cells were
transfected with HA-tagged ubiquitin (A) or FLAG-tagged HAUSP (B). After 24 hours the cells were pretreated with MG132 followed by UV (35 J/m2)
as shown and the cells were incubated for 6 hours. Cells were fixed and the expressed proteins were detected using HA- (A) or FLAG (B) -antibodies
and co-stained for NPM. Nucleolar areas were quantified from three independent experiments. C U2OS cells stably expressing USP36-Flag were
pretreated with MG132 followed by UV (35 J/m2) as shown and the cells were incubated for 3 hours. Cells were fixed and USP36 was detected using
FLAG-antibody and cells were co-stained for NPM. Nucleolar areas were quantified. D U2OS cells were treated with UbE1 inhibitor (10 mM) or left
untreated. After 24 hours the cells were exposed to UV (35 J/m2) and incubated for 3 hours. Cells were fixed and stained for NPM. Nucleolar areas
were quantified from two independent experiments. Scale bars 20 mm.
doi:10.1371/journal.pone.0059096.g006
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damage response pathways. Surprisingly, none of the major UV
damage-activated pathways, including MEK, JNK and p38 stress
signaling routes [19], or DNA damage sensors ATM, ATR and
DNA-PK kinase pathways, were prerequisite for the UV-mediated
changes in NPM localization. This indicated that the nucleolar
response to UV is largely independent of events that relate to the
known cellular UV stress responses.
Nucleolar proteins, including NPM are highly mobile [9,47].
Using photobleaching experiments of UV-treated live cells we
show here that the mobility of NPM increases over time, and that
NPM is highly diffusible 3 h after UV. These results indicate that
analogous to Pol I inhibition, NPM is released from its binding
partners like the 60S ribosome following UV damage [37,48]. In
contrast, the mobility of NPM decreases in cells treated with
MG132 [25,27] (Fig. 3). Inhibition of the proteasome function,
using specific catalytic inhibitors, effectively led to retention of
nucleolar NPM after UV. Although NPM was used as model
protein, other GC proteins (NCL, nucleostemin) were similarly
affected. The ability of the proteasome inhibitor to inhibit UV-
activated localization changes was evident on both endogenous
proteins and their fluorescent protein tagged variants. The effect of
combination of MG132 with UV treatment on the DFC and FC
proteins was more subtle. DFC and FP proteins, represented as
UBF and FBL, form nucleolar necklaces and cap structures
following transcription inhibition [38] and UV, and were largely
unaffected by the combinatory treatment.
A reasonable possibility is that NPM and other GC nucleolar
proteins undergo nucleolar translocation due to inhibition of Pol I
Figure 7. Inhibition of expression of 20S proteasome prevents NPM relocalization after UV radiation. U2OS cells were transfected with
specific siRNAs against 20S a (A) and 20S b (B) subunits and the cells were incubated for 72 hours. The cells were then treated with UV radiation (35 J/
m2) for 3 hours or left untreated. Cells were fixed and stained for NPM and 20S. Arrows indicate 20S silenced cells. C Nucleolar areas were quantified
from two independent experiments. Scale bars 20 mm.
doi:10.1371/journal.pone.0059096.g007
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transcription. From this perspective, it is noteworthy that
proteasome inhibition does not affect Pol I transcription, but does
inhibit rRNA processing [25,26]. Here, this was evident by the
decrease of the mature 28S RNA transcript following MG132-
treatment, while the synthesis of the 47S precursor rRNA was
intact. On the other hand, UV damage fully inhibited 47S
precursor rRNA transcription. Thus, although the nucleolar
expression of NPM, and several other GC proteins was retained
following proteasome inhibition, there was no compensatory
increase in Pol I transcription, suggesting that the relocation is a
cause, rather than effector, of Pol I inhibition.
In addition to its well understood role in protein degradation,
ubiquitin contributes to regulation of many cellular processes, like
membrane trafficking, protein kinase activation, DNA repair, and
chromatin dynamics [49]. Ubiquitin has important roles in DNA
damage response and repair, i.e. many DNA damage response
proteins catalyze ubiquitination or have ubiquitin binding
domains [49]. Protein ubiquitination is also involved in UV
damage repair [50]. Therefore ubiquitin could contribute to UV–
mediated NPM localization changes and its prevention by
proteasome inhibition. Further, we have recently shown that
proteotoxic stress causes the formation of a protein-RNA
aggregate into the nucleolus, and alters nucleolar organization
[27]. This aggregate contains nucleoplasmic proteasome target
proteins, such as p53 and MDM2, but not nucleolar proteins.
Moreover, the formation of the aggregate was alleviated by excess
free ubiquitin, suggesting that lack of ubiquitin recycling contrib-
utes to the aggregate formation [27]. We therefore manipulated
ubiquitin recycling in multiple ways, including increasing the pool
of free ubiquitin, overexpressing deubiquitinating enzymes
HAUSP and USP36, by inhibiting MDM2, an E3 ligase for
p53, and finally by inhibiting the conjugation of ubiquitin by E1
ligase inhibitor. However, none of these affected NPM localization
by UV. We conclude that ubiquitin per se is unlikely to have a role
in UV radiation –mediated NPM translocation. However, we
cannot exclude that these effects would be mediated by e.g. specific
deubiquitinases not tested in our assays, or that an alternative E1,
UBA6, could compensate for loss of E1 activity.
Consistent with inhibition of the proteasome catalytic activity by
the proteasome inhibitors, we considered that proteasomal
degradation is required for NPM relocation by UV. This was
despite that we did not observe any change in NPM expression or
half-life after UV or after proteasome inhibition, which is
unexpected of proteins conventionally considered as proteasomal
targets. However, the lack of correlation of protein ubiquitination
and increase in protein half-life has been highlighted in a recent
large-scale proteomic analysis for ubiquitin-modified proteome
[51]. This suggests that ultimately more selective techniques
should be in place to assess the potential alterations in protein
expression following proteotoxic stress. Notably, most ribosomal
proteins have much higher turnover rates in nucleoli as compared
to cytoplasm, whereas the turnover of NPM, NCL and GNL3 is
invariable [52]. These findings indicate that protein functional
associations impact their stability, and that the stabilities may vary
greatly in the subcellular compartments. Moreover, ribosomal
proteins are highly unstable when Pol I transcription is inhibited
by Actinomycin D [53], and following proteotoxic stress,
ribosomal proteins accumulate in the nucleoplasm where they
are presumed to undergo degradation [54]. These findings suggest
that rapid turnover of ribosomal proteins is promoted when Pol I
transcription is restricted, like in UV damaged cells. Accordingly,
downregulation of proteasomes by specifically silencing the 20S
core subunits a and b inhibited the UV–mediated NPM relocation
substantiating that the proteasome has an important contribution
for the phenotype. Hence, these results suggest the following
sequence of events. UV-damage causes repression of Pol I
transcription and consequently, nucleoplasmic redistribution of
nucleolar proteins or protein complexes. This could affect proteins
involved in late ribosome maturation, ribosomal proteins, stress-
responsive proteins or RNA-protein complexes that NPM
associates with [55]. Loss of functional protein interactions exposes
a subset of these proteins to proteasome-dependent degradation
whereas other proteins, such as NPM, are retained in the
nucleoplasm and display altered mobilities as reflection of changes
in their functional associations. This model further suggests that
inhibition of the proteasome limits degradation of protein(s)
required for stable nucleolar association of NPM.
These findings provide an intriguing insight for the relevance of
the proteasome activity in nucleolar protein fates and localization
following nucleolar stress. They substantiate the significance of the
proteasome in quality control of nucleolar proteins, rRNA and the
ribosomes and the tight coupling of Pol I transcription and
proteasome function. In future it will be pertinent to resolve how
the ubiquitin-proteasome function is involved in Pol I transcrip-
tion, rRNA processing and ribosome assembly and how it is
affected in cellular stress.
Materials and Methods
Plasmids
NPM-ECGFP fusion protein was generated as described [22].
USP36-FLAG was obtained from Origene. HA-Ub-wt/pcDNA3
was a kind gift from Dr I. Dikic (Goethe University, Frankfurt,
Germany [56]), and pCIneo-HAUSP-Flag (USP7) vector was
kindly provided by Dr B. Vogelstein (Johns Hopkins University,
Baltimore, MD, USA [57]).
Cell Culture, Chemicals, Treatments and Transfections
WS1 human skin fibroblasts (CRL-1502, ATCC) were main-
tained in DMEM supplemented with 10% FCS, non-essential
amino acids and penicillin-streptomycin. U2OS human osteosar-
coma cells (HTB-96, ATCC) were maintained in DMEM
supplemented with 15% FCS. A375 human melanoma cells
(CRL-1619, ATCC) and HeLa cervical adenocarcinoma cells
(CCL-2, ATCC) were maintained in DMEM supplemented with
10% FCS. Stable U2OS cell lines (NPM-ECGFP and USP36-
FLAG) were generated by transfecting the constructs by lipofec-
tion (Lipofectamine, Invitrogen), selection in the presence of G418,
and isolation of single cell colonies. Stable clones were maintained
in the presence of G418. All cells were maintained at +37uC in a
humidified atmosphere containing 5% CO2. Chemicals used were
U0126, SB203580, wortmannin, KU55933 and lactacystin
(Calbiochem), SP600125 (A. G. Scientific), NU7441 (Santa Cruz),
MG132 (Enzo/Biomol), UBE-41 (Biogenova) and Nutlin-3 (Alexis
Biochemicals). All other cell culture reagents were obtained from
Gibco-BRL and Sigma. Cells were treated with UVC using
254 nm UVC light bulbs (Stratalinker).
Fluorescent recovery after photobleaching
U2OS cells plated on Lab-Tek chambers (Nalge Nunc
International) were transfected with NPM-ECGFP by lipofection
(Lipofectamine, Invitrogen) or U2OS cells stably expressing NPM-
ECGFP were used [22]. The following day the growth medium
was replaced with DMEM without phenol red (Gibco-BRL). The
cells were maintained at +37uC using a heating stage or an
incubator during the imaging. Photobleaching and imaging was
performed using either Zeiss LSM510 META confocal micro-
scope equipped with 458 nm Argon laser at 85% output (7.3 A)
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and Plan-Neofluar 406/1.3NA Oil objective with 100% laser
power during the bleaching and at 2% during the imaging (Fig. 1
and Fig. S1), or Zeiss LSM510 DUO equipped with 488 nm
Argon laser at 50% output (6.1 A) and Plan-Apochromat 406/
1.3NA Oil objective with 100% laser power during the bleaching
and at 1% during the imaging (Fig. 3). ROI (region of interest) was
determined as single nucleolus, which was bleached after 3 pre-
scans with 30 iterations. 97 or 297 post-bleach images were
captured for Figures 1 and 3, respectively. Total intensity of the
nucleus and background ROIs were recorded simultaneously.
Fluorescent intensities were measured by LSM 510 Physiology
Software. Raw data was exported into Microsoft Office Excel
software to perform image analysis calculations according to [58].
Background fluorescent values were subtracted from each image,
the values were corrected to compensate the decrease in the total
intensity caused by scanning, and the results were normalized.




where Fend is the fluorescent intensity after reaching the plateau
(average of the last 20 scans), Fpost is the fluorescent intensity
immediately after the bleach, and Fpre before the bleach (average
of 3 pre-scans). Eight to nine cells were analyzed from at least two
independent experiments (Fig. 1) or five to eight cells from three to
four independent experiments (Fig. 3). Recovery half times were





Immunofluorescence and Image Analysis
Cells were fixed with 3.5% paraformaldehyde followed by
permeabilization with 0.5% NP-40. The following primary
antibodies were used: mouse anti-NPM (Zymed/Invitrogen),
rabbit anti-nucleostemin (GNL3, H-270, Santa Cruz), mouse
anti-NCL (Abcam), rabbit anti-UBF (H-300, Santa Cruz), rabbit
anti-FBL (Abcam), rabbit anti-HA (Y-11, Santa Cruz), rabbit anti-
FLAG (Sigma), rabbit anti-proteasome 20S core subunits
(PW8155, Enzo/Biomol) and rabbit anti-p53 (7F5, Cell Signaling
Technologies). Antibodies were detected with secondary antibod-
ies conjugated to Alexa 488 or 594 (Molecular Probes) and nuclei
were counterstained with either Hoechst 33258 or 33342. The
fluorochromes were visualized with Zeiss Axioplan 2 Imaging
MOT (Jena, Germany) epifluorescence microscope equipped with
206/0.5NA Plan-Neofluar objective and Chroma 31000v2,
Chroma 41001, and Chroma 41004 filters. Images were captured
with Zeiss AxioCam HRm 14-bit grayscale CCD camera and
AxioVision program version 4.6 and 4.7. Confocal imaging was
performed with Zeiss LSM510 META (Jena, Germany) micro-
scope equipped with 63/1.25 NA Plan-Neofluar objective, and
diode and HeNe lasers.
Images were quantified by Fiji/ImageJ-software. For quantifi-
cation of NPM signal intensity, cells were co-stained for NPM and
UBF. Nucleolar area was determined by UBF staining (UBF mask)
because UBF and NPM mask areas showed good overlap (87%)
indicating that UBF, which is retained in the nucleolar area even
after UV radiation, could be used as a surrogate marker for the
nucleolus. NPM mean intensity was then calculated from the UBF
mask area. Nucleoplasmic NPM intensity was determined by first
defining the nuclear area according to Hoechst staining (DNA
mask), followed by subtracting the UBF mask area. The remnant
was designated as nucleoplasmic area. NPM mean intensity in the
nucleoplasmic area was then determined, and NPM nucleolar/
nucleoplasmic ratios were calculated. NPM intensity ratios were
calculated from three independent experiments, each of which
contained two fields per treatment (N $ 140 cells). Image analysis
in Fig. 6 and 7 was conducted using FrIDA designed for the
analysis of RGB color image datasets [59]. Hue saturation and
brightness range were defined for transfected and non-transfected
cells and normalized to DNA. An average of 200 non-transfected
cells and 20 transfected cells was quantified from three-five fields
for each experiment.
P-values were calculated by Student’s two-tailed T test,
*P,0.05; **P,0.01; ***P,0.001.
Western Blotting
To obtain cellular lysates, cells were scraped, solubilized in
RIPA buffer (50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% NP-
40, 0.1% sodium dodecyl sulfate, 1% sodium deoxycholate)
supplemented with Complete Protease Inhibitor Tablets (Roche)
and sonicated in ice-cold water bath for 15 min or briefly by peak
sonicator followed by centrifugation at 13,000 rpm for 15 min.
Protein concentration was determined using Bio-Rad Bradford
protein assay (Bio-Rad, Hercules, CA). Equal amounts of protein
were loaded into 9% SDS-PAGE and transferred into nitrocellu-
lose membrane (Trans-Blot, Transfer Medium, Bio-Rad). Immu-
noblotting was carried out using mouse anti-NPM (Zymed/
Invitrogen), rabbit anti-GLN3 (Santa Cruz), mouse anti-NCL
(Abcam), mouse anti-UBF (F-9, Santa Cruz), rabbit anti-FBL
(Abcam), mouse anti-a-tubulin (clone B-5-1-2, Sigma), DO-1 (p53)
and rabbit anti-proteasome 20S core subunits (PW8155, Enzo/
Biomol) antibodies followed by incubation with secondary
antibodies conjugated either directly to horseradish peroxidase
or via biotin-streptavidin, after which the signals were detected
using enhanced chemiluminescence (ECL, Amersham Life
Sciences).
Ethynyl Uridine –labeling
Cells were labeled with 1 mM ethynyl uridine (EU, Invitrogen).
Cells were fixed and EU signal was detected using Click-iT RNA
Alexa FluorH 488 Imaging Kit (Invitrogen) according to manu-
facturer’s protocol. To quantify incorporation of EU, nuclei were
first identified by Hoechst staining and the EU mean intensity
values were collected from the nuclear areas from two indepen-
dent experiments. N= 50–70 cells were analyzed in each
experiment. P-values were calculated using Student’s two-tailed
T test.
Metabolic Labeling
3H-labeled uridine (Perkin Elmer, final concentration 2–4 mCi/
mL) was incubated with the cells for the last 1–2 hours. RNA was
extracted by NucleoSpin RNA II kit (Macherey-Nagel) and RNA
concentrations were measured with NanoDrop. Equal amounts of
RNA was separated on 1% formaldehyde-agarose gel and
transferred onto Hybond-N+ 2filter (Amersham). The filter was
cross-linked and sprayed with EN3HANCE (Perkin Elmer).
Autoradiographs were developed 2 to 7 days later.
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U2OS cells were plated on coverslips and transfected with
specific siRNAs either at the time of plating or the following day.
The following siRNAs were used: Hs_PSMA3_5 FlexiTube
siRNA (SI00301434, Qiagen) for 20Sa and Hs_PSMB1_2
FlexiTube siRNA (SI00301455, Qiagen) for 20Sb.
Supporting Information
Figure S1 NPM nucleoplasmic mobility is high follow-
ing UV radiation. A U2OS cells were transiently transfected
with NPM-ECGFP and were treated with UVC (35 J/m2) for
6 hours. FRAP analysis was performed on nucleoplasm as
indicated by ROI (red circle). Following photobleaching images
were captured every 1 s for 100 s. Representative images are
shown. Scale bar 10 mm. B Averages of normalized intensities and
the mobile fraction from at least two independent experiments is
shown. Error bars, SD. N=10 cells.
(TIF)
Figure S2 Inhibition of DNA damage or UV-activated
cell stress signaling pathways do not affect UV-mediated
NPM relocalization. U2OS cells were treated with inhibitors
targeting UV-activated cellular signaling (U0126 10 mM for MEK,
SB203580 20 mM for p38 and SP600125 100 mM for JNK), DNA
damage signaling (KU55933 10 mM for ATM, wortmannin
100 mM for ATM/ATR and NU7441 10 mM for DNA-PK) and
proteasome (MG132 10 mM) or left untreated. One hour later the
cells were exposed to UV radiation (35 J/m2) or left untreated.
Cells were fixed after 3 hours and stained for NPM. Scale bar,
50 mm.
(TIF)
Figure S3 NPM relocalization is not antibody-specific
and NPM protein levels remain constant in different cell
lines. A U2OS cells stably expressing NPM-ECGFP were treated
with MG132 or left untreated. After 2 hours the cells were treated
with UV (35 J/m2) and incubated for 6 hours. Scale bar 20 mm. B
HeLa and U2OS cells were pretreated with MG132 and UV
(35 J/m2) as shown. After 3 hours cells were lysed with RIPA
buffer. Equal amounts of total protein were separated by SDS-
PAGE and immunoblotted for NPM. Tubulin was used as a
loading control.
(TIF)
Figure S4 NPM half-life is unaltered following UV
damage. A and B, U2OS cells were treated with UV (35 J/m2)
and incubated in the presence or absence of cycloheximide (CHX,
50 mg/ml) for the indicated times. Cell lysates were prepared and
analyzed by immunoblotting for NPM and GAPDH as control. C,
U2OS cells were treated with UV (35 J/m2) in the presence or
absence of cycloheximide (50 mg/ml) and incubated for 3 h. Fixed
cells were stained for NPM (red) and DNA (blue). D, U2OS cells
were treated with UV (35 J/m2) in the presence or absence of a-
amanitin (25 mg/ml) and incubated for 3 h. Fixed cells were
stained for NPM (red) and DNA (blue).
(TIF)
Figure S5 Nutlin-3 does not affect NPM redistribution
after UV. U2OS cells were treated with either Nutlin-3 (10 mM)
or UV (35 J/m2), or pretreated with Nutlin-3 for 1 hour followed
by UV treatment and incubated for 3 hours, or left untreated
(control). The cells were fixed and stained for NPM and p53. Scale
bar, 20 mm.
(TIF)
Figure S6 UbE1 inhibitor induces p53 response. WS1
cells were treated with UV (35 J/m2) or UbE1 inhibitor (10 mM)
and incubated for 19 hours or left untreated. The cells were fixed
and stained for p53.
(TIF)
Figure S7 Silencing of 20S proteasome. HeLa cells were
transfected with specific siRNAs against 20S a proteasome and the
cells were incubated for 72 hours. Equal amounts of total protein
were separated by SDS-PAGE and immunoblotted for p53 and
20S. Tubulin was used as a loading control.
(TIF)
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